Home/Filings/4/0001182615-14-000023
4//SEC Filing

SEQUENOM INC 4

Accession 0001182615-14-000023

CIK 0001076481operating

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:59 PM ET

Size

9.6 KB

Accession

0001182615-14-000023

Insider Transaction Report

Form 4
Period: 2014-02-01
BOMBARD ALLAN
Chief Medical Officer
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2014-02-01+27,88727,887 total
    Exercise: $2.27Exp: 2024-01-31Common Stock (27,887 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2014-02-01+52,11352,113 total
    Exercise: $2.27Exp: 2024-01-31Common Stock (52,113 underlying)
  • Award

    Restricted Stock Unit

    2014-02-01+40,00069,900 total
    Common Stock (40,000 underlying)
Footnotes (3)
  • [F1]The shares subject to the option began vesting in 48 equal monthly installments commencing on 2/1/14, such that the shares subject to the option are fully vested on 2/1/18.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]The shares subject to the restricted stock unit began vesting in 4 equal annual installments commencing on 2/1/14, with annual vesting dates on 2/10/15, 2/10/16, 2/10/17 and 2/10/18 such the shares subject to the restricted stock units are fully vested on 2/10/18.

Issuer

SEQUENOM INC

CIK 0001076481

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001076481

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:59 PM ET
Size
9.6 KB